MONDAY, June 9, 2025 (HealthDay News) — Prompt treatment with a drug combo can effectively manage chronic kidney disease in people with type 2 diabetes, a new clinical trial shows. Patients prescribed the combination of finerenone and empagliflozin experienced a 52% decrease in their urinary albumin-to-creatinine ratio, researchers report inContinue Reading
FRIDAY, June 6, 2025 (HealthDay News) — A repurposed diabetes drug can be an effective tool against fatty liver disease, a new clinical trial has found. Dapagliflozin helped people reduce fat levels in their liver and avoid liver scarring that comes with the condition, which doctors call metabolic dysfunction-associated steatohepatitis,Continue Reading
FRIDAY, May 30, 2025 (HealthDay News) — Twice as many Americans now face the increased risk of death that comes from having both high blood pressure and type 2 diabetes, a new study reports. About 12% of the U.S. population had high blood pressure and type 2 diabetes at theContinue Reading
THURSDAY, May 29, 2025 (HealthDay News) — Heart disease, strokes and diabetes contribute to many dementia cases in the United States, but the risk is not equal everywhere, a new study says. Overall, more than a third (37%) of U.S. dementia cases are linked to eight conditions: diabetes, heart failure,Continue Reading
WEDNESDAY, May 28, 2025 (HealthDay News) — Preschoolers who don’t naturally lose weight are more likely to develop full-fledged childhood obesity by age 9, a new study says. Most kids tend to see their body-mass index (BMI) decline between ages 1 and 6, before starting to slowly gain weight asContinue Reading
WEDNESDAY, May 28, 2025 (HealthDay News) — Popular GLP-1 weight loss drugs like Ozempic and Zepbound can help reduce a woman’s risk for as many as 14 cancers associated with obesity, a new study says. People taking a GLP-1 drug had a 7% lower risk of developing an obesity-related cancerContinue Reading
WEDNESDAY, May 21, 2025 (HealthDay News) — Battling chronic disease really takes it out of a person, leaving them vulnerable to depression. And people with multiple long-term health problems are even more likely to fall prey to depression, a new study says. Some combinations of illnesses can more than doubleContinue Reading
FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases. The deal could be worth up to $2.2 billion for Septerna. This includes more than $200 million inContinue Reading
FRIDAY, May 16, 2025 (HealthDay News) — People who develop type 1 diabetes in adulthood have a higher risk of heart disease and death, a new study says. However, these patients can improve their odds through healthy lifestyle habits, researchers reported May 14 in the European Heart Journal. “We showContinue Reading
WEDNESDAY, May 7, 2025 (HealthDay News) — Persistently high blood sugar among teenagers can lead to heart disease by young adulthood, a new study says. Teenagers had up to three times the risk of developing a heart condition called left ventricular hypertrophy if their blood sugar remained persistently high betweenContinue Reading